Notman Donald, COO of Ocular Therapeutix ($OCUL), made four open market sales of company shares over the past year, totaling about $218 thousand. His most recent sale occurred on February 12, 2026. These transactions rank 8,236th among 11,678 insiders by sale value, well below the average of 8.6 million per seller and 6.4 transactions. He reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | Chief Operating Officer | S | Common Stock | 11446 | $9.04 | 366,356.0000 | 187,241,483 | 3.03% | 0.01% |
| Feb. 4, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | Chief Operating Officer | S | Common Stock | 6035 | $8.54 | 377,802.0000 | 187,241,483 | 1.57% | 0.00% |
| Feb. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | Chief Operating Officer | S | Common Stock | 5455 | $9.14 | 383,837.0000 | 187,241,483 | 1.40% | 0.00% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | A | Common Stock | 79112 | $0.00 | 389,292.0000 | 187,241,483 | 25.51% | 0.04% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | A | Stock Option (Right to Buy) | 240932 | $0.00 | 240,932.0000 | 187,241,483 | 9999.99% | 0.13% |
| Sept. 2, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | S | Common Stock | 1066 | $12.43 | 308,807.0000 | 172,594,662 | 0.34% | 0.00% |
| Feb. 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | A | Common Stock | 115000 | $0.00 | 308,444.0000 | 158,265,162 | 59.45% | 0.07% |
| Feb. 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | A | Stock Option (Right to Buy) | 344115 | $0.00 | 344,115.0000 | 158,265,162 | 9999.99% | 0.22% |
| Feb. 4, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | S | Common Stock | 11119 | $7.81 | 193,444.0000 | 158,265,162 | 5.44% | 0.01% |
| Jan. 31, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | S | Common Stock | 6301 | $7.84 | 204,563.0000 | 158,265,162 | 2.99% | 0.00% |
| Aug. 29, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | A | Stock Option (Right to Buy) | 33602 | $0.00 | 33,602.0000 | 165,824,778 | 9999.99% | 0.02% |
| Aug. 29, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | See Remarks | A | Common Stock | 11034 | $0.00 | 208,988.0000 | 165,824,778 | 5.57% | 0.01% |
| Feb. 3, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | Chief Financial Officer | A | Stock Option (Right to Buy) | 185000 | $0.00 | 185,000.0000 | 85,596,594 | 9999.99% | 0.22% |
| Feb. 5, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | Chief Financial Officer | S | Common Stock | 6212 | $4.86 | 195,356.0000 | 85,596,594 | 3.28% | 0.01% |
| Feb. 3, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | Chief Financial Officer | A | Common Stock | 61636 | $0.00 | 201,568.0000 | 85,596,594 | 44.05% | 0.07% |
| Jan. 31, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Notman Donald | Chief Financial Officer | S | Common Stock | 6433 | $4.95 | 139,932.0000 | 85,596,594 | 4.40% | 0.01% |